Leading healthcare technology firm Medtronic is reportedly looking to acquire UK-based Smith & Nephew, a deal reports say could shift Medtronic’s finances overseas.
The US firm, which is the largest manufacturer of heart rhythm technologies, is evaluating a possible acquisition of the London company, which currently has a market value of nearly $16 billion. While unnamed sources first broke news of the possible merger, they noted that a deal has not been struck and preparations for a bid are only in their preliminary stage.
But a Medtronic offer for Smith & Nephew would rival one from rival US medial tech company Stryker, which confirmed last week that it was also considering placing a bid for the UK company./p>
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Competition Watchdog to Investigate Carlsberg’s £3.3bn Takeover of Britvic
Sep 11, 2024 by
CPI
News Corp Faced Millions in Losses by Moving Away from Google Ads, Ex-Executive Testifies
Sep 10, 2024 by
CPI
EU Faces Critical Innovation Gap, Draghi Report Urges Antitrust Reforms
Sep 10, 2024 by
CPI
Womble Bond Dickinson and Lewis Roca to Merge, Forming 1,300-Lawyer Firm
Sep 10, 2024 by
CPI
Federal Judge Dismisses Antitrust Lawsuit Against Fidelity and Schwab
Sep 10, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
CPI
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
CPI
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
CPI
The Cost of Making COFECE Disappear
Sep 3, 2024 by
CPI